WallStSmart

Buda Juice, Inc. (BUDA)vsCoca-Cola European Partners PLC (CCEP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Coca-Cola European Partners PLC generates 167295% more annual revenue ($20.90B vs $12.49M). BUDA leads profitability with a 30.6% profit margin vs 9.3%. CCEP trades at a lower P/E of 18.7x. CCEP earns a higher WallStSmart Score of 59/100 (C).

BUDA

Avoid

32

out of 100

Grade: F

Growth: 6.0Profit: 7.0Value: 5.7Quality: 5.0

CCEP

Buy

59

out of 100

Grade: C

Growth: 6.7Profit: 6.5Value: 7.3Quality: 5.5
Piotroski: 3/9Altman Z: 1.55
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

BUDASignificantly Overvalued (-501.4%)

Margin of Safety

-501.4%

Fair Value

$1.43

Current Price

$9.47

$8.04 premium

UndervaluedFair: $1.43Overvalued
CCEPUndervalued (+57.7%)

Margin of Safety

+57.7%

Fair Value

$230.72

Current Price

$93.23

$137.49 discount

UndervaluedFair: $230.72Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BUDA2 strengths · Avg: 9.0/10
Profit MarginProfitability
30.6%10/10

Keeps 31 of every $100 in revenue as profit

Operating MarginProfitability
27.2%8/10

Strong operational efficiency at 27.2%

CCEP3 strengths · Avg: 9.0/10
EPS GrowthGrowth
68.3%10/10

Earnings expanding 68.3% YoY

Return on EquityProfitability
22.9%9/10

Every $100 of equity generates 23 in profit

Free Cash FlowQuality
$1.51B8/10

Generating 1.5B in free cash flow

Areas to Watch

BUDA4 concerns · Avg: 2.5/10
Market CapQuality
$119.43M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

P/E RatioValuation
43.5x2/10

Premium valuation, high expectations priced in

Price/BookValuation
24.9x2/10

Trading at 24.9x book value

CCEP4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
0.2%4/10

0.2% revenue growth

Altman Z-ScoreHealth
1.554/10

Distress zone — elevated risk

Debt/EquityHealth
1.503/10

Elevated debt levels

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : BUDA

The strongest argument for BUDA centers on Profit Margin, Operating Margin. Profitability is solid with margins at 30.6% and operating margin at 27.2%.

Bull Case : CCEP

The strongest argument for CCEP centers on EPS Growth, Return on Equity, Free Cash Flow.

Bear Case : BUDA

The primary concerns for BUDA are Market Cap, Return on Equity, P/E Ratio. A P/E of 43.5x leaves little room for execution misses.

Bear Case : CCEP

The primary concerns for CCEP are Revenue Growth, Altman Z-Score, Debt/Equity.

Key Dynamics to Monitor

BUDA profiles as a mature stock while CCEP is a value play — different risk/reward profiles.

BUDA is growing revenue faster at 9.1% — sustainability is the question.

CCEP generates stronger free cash flow (1.5B), providing more financial flexibility.

Monitor BEVERAGES - NON-ALCOHOLIC industry trends, competitive dynamics, and regulatory changes.

Bottom Line

CCEP scores higher overall (59/100 vs 32/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Buda Juice, Inc.

CONSUMER DEFENSIVE · BEVERAGES - NON-ALCOHOLIC · USA

Buda Juice, Inc. engages in producing and distributing UltraFresh juices, lemonades, limeades, and wellness shots. The company is headquartered in Dallas, Texas.

Coca-Cola European Partners PLC

CONSUMER DEFENSIVE · BEVERAGES - NON-ALCOHOLIC · USA

Coca-Cola Europacific Partners PLC produces, distributes and sells a variety of ready-to-drink non-alcoholic beverages. The company is headquartered in Uxbridge, the United Kingdom.

Visit Website →

Want to dig deeper into these stocks?